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Abstract
Background:Model-based compartmental analysis of data on plasma retinol kinetics after administration of labeled retinol
provides unique information about whole-body vitamin Ametabolism. If labeled b-carotene is coadministered, its bioefficacy
relative to the retinol reference dose can also be estimated.
Objectives: The objectives were to model plasma retinol kinetics after administration of labeled preformed vitamin A and
provitamin A b-carotene and to determine relative b-carotene bioefficacy.
Methods:We used the Simulation, Analysis andModeling software (WinSAAM version 3.0.8; http://www.WinSAAM.org) to
analyze previously collected data on plasma [13C10]- and [
13C5]retinol kinetics for 14 d after oral administration of 1 mg [
13C10]
retinyl acetate and 2mg [13C10]b-carotene in oil to 30 healthy young adults of European ancestry [13men, 17women;mean6
SD age: 24.5 6 4.2 y; mean 6 SD body weight: 65.2 6 10 kg; mean 6 SD body mass index (in kg/m2): 22.5 6 1.9] with
moderate vitamin A intakes.
Results: A 6-component model provided the best fit to the data, including compartments for initial metabolism of vitamin
A, plasma retinol, and extravascular vitamin A storage. The disposal rate was 6.7 6 3.1 mmol/d, fractional catabolic rate
was 6.0%6 2.3%/d, and vitamin A stores were 1236 71 mmol. Relative b-carotene bioefficacy, based on the ratio of the
areas under the fraction of dose curves calculated by WinSAAM, averaged 13.5% 6 6.02% (retinol activity equivalents =
7.7:1.0 mg). Interindividual variation in relative b-carotene bioefficacy was high (CV: 44%).
Conclusions: Vitamin A kinetics in these young adults were best described by essentially the samemodel that had been previously
developed by using data for older adultswith higher vitamin A stores; differences in parameter values reflected differences in vitamin
A status. Estimated b-carotene bioefficacy was relatively low but similar to previously reported estimates obtained by graphical
methods. This trial was registered at the UK Clinical Research Network as UKCRN 7413. J Nutr doi: 10.3945/jn.116.233486.
Keywords: area under the curve, humans, bioefficacy, bioconversion, carotenoids, isotope dilution, retinoids,
retinol kinetics, vitamin A deficiency, WinSAAM
Introduction
Model-based compartmental analysis [specifically, the Simula-
tion, Analysis and Modeling software (WinSAAM; http://www.
WinSAAM.org) (1)] has been productively used to describe and
quantitate retinol kinetics in rats over the past 35 y [see refer-
ence 2 for a review as well as Tan et al. (3)]. This approach has
generated unique and important insights into whole-body
vitamin A metabolism, including the fact that there is extensive
recycling of retinol among plasma and tissues before irreversible
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utilization. On the basis of several small, retrospective analyses,
general features of the vitamin A system are assumed to be
the same in both rats and humans (2). In a published report
based on a larger sample of humans, Cifelli et al. (4) presented a
6-component model for whole-body vitamin A metabolism in
Chinese and American adults (n = 26). Results were based on
plasma [2H8]retinol data collected for 56 d after the oral ad-
ministration of deuterated retinyl acetate. Both groups in that
study had moderate vitamin A stores, unlike the case in many
lower-income populations worldwide for whom vitamin A
deficiency and/or low vitamin A status are important public
health problems.
In addition to information on vitamin A kinetics, WinSAAM
can also be used to estimate relative b-carotene bioefficacy if a
stable isotope of b-carotene is coadministered with labeled
retinol. b-Carotene bioefficacy is defined as the proportion of
ingested b-carotene that is absorbed and converted to retinol (5).
The bioefficacy of a given b-carotene dose is estimated by
dividing the area under the plasma isotope response curve
(AUC)8 from time zero to infinity for labeled retinol derived
from the b-carotene dose by the AUC for labeled retinol derived
from the coadministered retinol reference dose. In previous
studies (6–8), researchers used graphical methods to calculate
AUCs from time zero to the end of their experiment and then
calculated relative b-carotene bioefficacy as the ratio of the AUCs
(‘‘isotope reference method’’). Note that such ratio methods
reflect b-carotene absorption and bioconversion relative to the
absorption and metabolism of the retinol reference dose. Because
the literature indicates that b-carotene bioefficacy is affected by
many factors (9), and varies widely depending on source, accurate
methods for estimating b-carotene bioefficacy are needed.
In the current study, we applied model-based compartmental
analysis to the data of Oxley et al. (10) on plasma retinol kinetics
in a group of healthy young adults who had received single oral
doses of [13C10]b-carotene and [
13C10]retinyl acetate in oil. Our
goals were to extend the knowledge on whole-body vitamin A
metabolism in a population not previously studied and to
compare model-generated estimates of b-carotene bioefficacy
with graphical estimates. Because participants in the current
study were selected to have moderate vitamin A intakes and
were found to have relatively low vitamin A stores, our results
may be generalizable to populations in lower-income countries
who may be at risk of vitamin A deficiency.
Methods
Stable isotopes. As reported by Oxley et al. (10), [13C10]retinyl acetate
(8, 9, 10, 11, 12, 13, 14, 15, 19, 20-[13C10]retinyl acetate; molecular
weight: 338.4) and [13C10]b-carotene (12, 12#, 13, 13#, 14, 14#, 15, 15#,
20, 20#-[13C10]b-carotene; molecular weight: 546.8) were purchased
from Buchem BV. The isomeric composition of purchased [13C10]b-
carotenewas retrospectively determined to be 88.5% all-trans-b-carotene,
10.0% cis-b-carotene, and 1.5% a-carotene.
Subjects. Healthy young adults of European ancestry were recruited by
Oxley et al. (10). Subjects had not consumed b-carotene or multivitamin
supplements containing vitamins A, C, and E during the 3 mo before the
study and were excluded for the following reasons: being a smoker; being
pregnant; having a BMI (in kg/m2) >30, high blood pressure, diabetes, lipid
metabolic disorders, or liver, kidney, or gastrointestinal disease (as
determined by a health and lifestyle questionnaire and blood test results);
or consuming a diet high in preformed vitamin A (as determined by an
FFQ). For the current modeling analysis, 15 of the 45 participants from the
Oxley et al. study (10) were excluded because either their plasma isotope
response curves did not follow the expected pattern of steady state tracer
kinetics or there were anomalies in their data (see later in text). The study
was conducted according to the guidelines set forth in the Declaration of
Helsinki; written consent was obtained from each participant. All of the
procedures were approved by the National Research Ethics Service, North
East–Sunderland Committee (REC 09/H0904/20) before registration with
the UK Clinical Research Network (UKCRN: 7413).
Study design. Details on the 2-wk kinetic study were reported by
Oxley et al. (10). Briefly, isotopes were separately dissolved by
sonication in sunflower oil at concentrations of 2 g/L for [13C10]b-
carotene and of 1 g/L for [13C10]retinyl acetate. One milliliter of each
solution was administered to each subject (see below); thus, subjects
received 2.954 mmol [13C10]retinyl acetate (‘‘[
13C10]retinol dose’’)
and 3.237 mmol [13C10]all-trans-b-carotene, 0.366 mmol [
13C10]cis-
b-carotene, and 0.055 mmol [13C10]a-carotene (‘‘b-carotene dose’’).
Knowing that 1 molecule of all-trans-b-carotene could maximally be
absorbed and converted into 2 molecules of retinol, whereas cis-b-carotene
or a-carotene could yield only 1 retinol molecule, the value for the
[13C10]b-carotene dose was calculated to be 6.895 mmol retinol activity
equivalents (RAEs) (9).
For the kinetic study, volunteers consumed a standardized pasta meal,
along with water, the evening before the experiment started and then
fasted overnight. In the morning, a cannula was inserted in an antecubital
vein in each subject. Subjects were sequentially given the doses of
[13C10]b-carotene and [
13C10]retinyl acetate orally via a syringe and then
consumed a muffin and a yogurt smoothie (56% of total calories from
fat). Blood was collected into 10-mL EDTA-coated evacuated tubes
before administration of the dose (0 h) and at 2, 4, 6, 8, 10, and 12 h after
dosing; cannulas were then removed. Subsequent fasting blood samples
were obtained by venipuncture at 1, 2, 7, and 14 d. Blood samples were
centrifuged at 1300 3 g for 10 min at 4C immediately after collection;
plasma was stored at –80C until analysis.
Analytical procedures. Lipids including b-carotene and retinoids were
extracted from plasma and analyzed by LC–tandem mass spectrometry
(LC-MS/MS) according to the method of Oxley et al. (10). Briefly, 1 mL
plasma was extracted by using 10 mL ethanol/ethyl acetate (50:50
vol:vol) with the use of [13C10]retinyl acetate and [
13C20]b-carotene
as internal standards. Solvent extracts were dried under a gentle stream
of nitrogen, and the residues were reconstituted in 100 mL ethyl acetate.
Analytes were separated by reverse-phase HPLC before MS/MS quan-
titation under atmospheric pressure chemical ionization in positive ion
mode. Selected reaction monitoring of analytes was performed at m/z
547/330 and m/z 274/98 for [13C10]b-carotene and [
13C5] cleavage
products and at m/z 279/100 for metabolites of [13C10]retinyl acetate.
[12C]Retinol in plasma was quantified by HPLC (11).
Kinetic analysis and parameters. The fraction of the oral dose (FD) in
plasma for both [13C5]retinol (derived from [
13C10]b-carotene) and
[13C10]retinol (derived from [
13C10]retinyl acetate) at each time for each
subject was calculated as follows:
FD ¼fplasma ½13Cretinol concentration ðmmol=LÞ
3 estimatedplasmavolume ðLÞg=½13Cdose ðmmolÞ ð1Þ
where estimated plasma volume (L) = body weight (kg) 3 0.0435 (L/kg)
(7). To accurately calculate [13C10]retinol and [
13C5]retinol FD, back-
ground MS/MS analytical noise was subtracted for each sample.
By using WinSAAM (1), the data for plasma [13C10]retinol FD vs.
time were fit to a model modified from the one developed by Cifelli et al.
(4) to describe serum isotope data after the oral administration of [2H8]
retinyl acetate to Chinese and American subjects. In this type of simple
model, processes with similar kinetics are aggregated into the same compart-
ment. In the current 6-component model (Figure 1A), compartment 1 is
8 Abbreviations used: AUC, area under the plasma isotope response curve; FCR,
fractional catabolic rate; FD, fraction of the oral dose; FSD, fractional standard
deviation; L(I,J), fractional transfer coefficient; MS/MS, tandem mass spec-
trometry; RAE, retinol activity equivalent; RBP, retinol-binding protein.
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the site of introduction of the stable isotopes and dietary vitamin A into
the system, as well as the site of loss of unabsorbed tracer. Retinol
absorption efficiency was fixed at 75% on the basis of previous work in
rats (12). Compartment 2 represents retinol in enterocytes; from there,
retinol either transfers to delay component 3 or goes directly to plasma
compartment 5. Delay component 3 is a WinSAAM device used here to
accommodate the processes of chylomicron production and metabo-
lism as well as the uptake of chylomicron remnants by hepatocytes.
Compartment 4 corresponds to hepatic processing of retinyl esters from
chylomicron remnants and hepatic secretion of retinol bound to retinol-
binding protein (RBP). Compartment 5 represents retinol bound to RBP/
transthyretin in plasma; this retinol exchanges with vitamin A in an
extravascular pool (compartment 6). Compartment 6 comprises vitamin
A stores and is the systems site of irreversible loss of vitamin A [i.e.,
retinol that is converted to retinoic acid or other polar metabolites that
cannot chemically convert back to retinol; represented here as L(10,6)].
In Figure 1A, themodel parameters (fractional transfer coefficients [L(I,J)s])
correspond to the fraction of retinol in compartment J that is transferred
to compartment I each day; for example, the fractional transfer of
retinol to compartment 6 (stores) from compartment 5 (plasma) is
L(6,5) (d21) and the fractional transfer of retinol back to plasma from
stores is L(5,6) (d21). Parameters were systematically adjusted in
WinSAAM to obtain a satisfactory fit of the data to the model for
each subject. Final estimates for the L(I,J)s and their statistical
uncertainties were generated by using weighted nonlinear regression
analysis in WinSAAM. A fractional standard deviation (FSD) of 0.05
was used as the weighting factor.
The following kinetic parameters were then calculated by using the
L(I,J)s for each individual [see Cifelli et al. (2) and Green et al. (13) for
more details on these calculations]. The time for the retinol tracer to
appear in plasma after the ingestion of the oral dose [mean time to
plasma (time it takes for 50% of the absorbed tracer to reach plasma
bound to RBP; TTP50%)] was calculated as the time at which 50% of
the absorbed tracer was present in plasma compartment 5 (holoRBP).
Plasma retinol pool sizes (mmol) were estimated from each individuals
mean plasma [12 C]retinol concentration during the study (determined
by HPLC) and their estimated plasma volume. Then, plasma retinol pool
sizes were used in a steady state solution in WinSAAM to estimate
vitamin A pool sizes or traced mass [M(I); mmol]; disposal rate (mmol/d),
or the rate of loss of vitamin A from compartment 6; and system
fractional catabolic rate (FCR; d21), or the fraction of retinol in com-
partment 6 that leaves irreversibly each day. Other parameters that were
calculated include the half-life [t1/2(J)] for retinol in compartments 5 and
6, where t1/2(J) = ln 2/+L(I,J)s exiting compartment J. The mean residence
time [T(I,J)] is the mean time the tracer spends in compartment I after
entering the system via compartment J; thus, residence time in plasma
for absorbed retinol is T(5,5) and residence time in stores is T(6,5).
T(SYS) [T(5,5) + T(6,5)] is the total time the tracer spends in plasma
and stores from the time it enters plasma until it irreversibly leaves
the system. The recycling number [v(5)] is the average number of times a
retinol molecule recycles to plasma before irreversible loss; v(5) = {[T(5,5)/
t1/2(5)] – 1}. Finally, the recycling time to plasma [tt(5)] was calculated as
[T(6,5)/v(5)].
Once the data had been modeled for [13C10]retinol, a parallel model
was formulated (see Results) for plasma [13C5]retinol (i.e., labeled
retinol derived from the [13C10]b-carotene dose) and WinSAAM was
used as above to calculate additional model parameters as well as relative
b-carotene bioefficacy.
b-Carotene bioefficacy. We used WinSAAM to calculate the relative
efficiency of absorption and conversion of b-carotene to retinol. This
was done by dividing the AUC for the FD in plasma b-carotene–derived
FIGURE 1 Proposed compartmental model for retinol kinetics in humans. Circles represent compartments; components 3 and 13, shown as
rectangles, are delay elements, and interconnectivities between compartments [L(I,J)s] are fractional transfer coefficients or the fraction of
retinol in compartment J that is transferred to compartment I each day. Panel A shows the model for [13C10]retinol and panel B shows the parallel
model for [13C5]retinol (which was derived from the [
13C10]b-carotene dose). In panel A, compartments 1–4 (including component 3) correspond
to vitamin A digestion and absorption, loss of unabsorbed vitamin A, chylomicron production and metabolism, hepatocyte uptake of chylomicron
remnant retinyl esters, and hepatic processing of retinol. Compartment 5 represents plasma retinol bound to retinol-binding protein and
transthyretin; this retinol exchanges with vitamin A in 1 extravascular pool (compartment 6), which includes vitamin A stores in liver and other
organs; thus, the fractional transfer of retinol to compartment 6 (stores) from compartment 5 (plasma) is L(6,5) (d21) and the fractional transfer of
retinol back to plasma from stores is L(5,6) (d21). The asterisks (*) represent the site of input of the orally administered [13C] stable isotopes, and
U(1) represents dietary vitamin A input. Absorption efficiency was fixed at 75%; thus, the fraction of the dose not absorbed is L(0,1) = 0.333 3
L(2,1) because 25% is one-third of 75%. L(5,2) [and L(15,12) in the parallel model] represents the possibility that some retinol may be absorbed
via the portal vein or picked up from the surface of chylomicrons; this parameter was required to fit the first data point. In panel B, compartments
11 and 12 represent b-carotene digestion and absorption; compartment 12 corresponds to the bioconversion of absorbed b-carotene to retinol in
enterocytes. The remaining parts of the model are the same as in panel A, with L(16,15) = L(6,5), L(15,16) = L(5,6), and L(20,16) = L(10,6). L(I,J),
fractional transfer coefficient. Adapted from reference 4 with permission.
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retinol integrated from time zero to infinity by the AUC for the FD in
plasma retinyl acetate–derived retinol integrated from time zero to
infinity. In WinSAAM, AUC is calculated as the L-inverse matrix, which
is equal to the residence time for retinol in plasma after it enters the
system orally [T(15,11) and T(5,1), respectively]. We also calculated
relative bioefficacy by using the graphical method described by Tang et al.
(6), in which AUCs from time zero to the end of the experiment (14 d)
were estimated for each isotope by using KaleidaGraph (version 4.1;
Synergy Software).
Statistical methods. Data are presented as means6 SDs. Graphs were
made by using GraphPad Prism (version 6; GraphPad Software), and
statistical analyses were performed by using JMP Pro (version 12.1; SAS
Institute). P < 0.05 was considered significant. Students paired t test and
linear least-squares regression analysis were used to compare b-carotene
bioefficacy calculated by using WinSAAM compared with KaleidaGraph.
Pearsons correlation coefficient (r) and Spearmans rank correlation
coefficient (Rs) were determined.
Results
Participant characteristics. Subjects (n = 30) were healthy
young adults of European ancestry (13 men and 17 women) with
a mean 6 SD age of 24.5 6 4.2 y, mean 6 SD body weight of
65.2 6 10 kg, and mean 6 SD BMI of 22.5 6 1.9. The
recruitment strategy selected volunteers with moderate intakes of
preformed vitamin A, as determined by using the EPIC (European
Prospective Investigation into Cancer and Nutrition) FFQ (14).
As shown in Table 1, volunteers consumed 461 6 501 mg retinol
and 4.6 6 4.4 mg b-carotene/d; carbohydrate, fat, and protein
contributed 49.4%, 32.4%, and 15.3%, respectively, to total
energy intake. During the 14-d study, mean plasma retinol
concentrations measured by HPLC were normal for all subjects
(mean 6 SD 1.53 6 0.27 mmol/L; range: 1.13–2.32 mmol/L).
Data for 15 other subjects studied by Oxley et al. (10) were
excluded from this analysis on the basis of the following criteria:
1) data were missing at critical time points (n = 1) or the FD was
negative after background subtraction (n = 3) or 2) plasma
isotope response curves did not follow the expected pattern of
steady state tracer kinetics as evidenced by a positive terminal
slope for [13C5]- and [
13C10]retinol curves (n = 3), the 2 curves
converged (n = 3) or diverged (n = 1) over time, or there was an
abnormally high peak value for [13C10]retinol (n = 4).
Kinetic data and compartmental model for [13C10]retinol.
Data for FD in plasma [13C10]retinol vs. time for 1 representative
subject are plotted in Figure 2 (upper curve); also shown is the
model-simulated fit to the data. Plasma [13C10]retinol peaked at
;12 h and then fell as tracer was distributed to extravascular
tissues. The bend in the curve at ;2 d indicates tracer recycling
to plasma; the curve then enters a terminal slope, reflecting the
system FCR for vitamin A. When fitting the data to the model
shown in Figure 1, the model was sensitive to specific parameters
at different times, as indicated in Figure 2. For example, L(5,4)
and L(6,5) have their main impacts on the peak in the plasma
retinol response profile and on the initial decrease after the peak,
L(5,6) affects the bend in the curve from 2 to 6 d after dosing,
and the terminal slope is most sensitive to L(10,6).
Mean model-predicted kinetic parameters for the 30 subjects
are listed in Table 2. Three parameters related to the initial
stages of the model [L(2,1), L(5,2), and L(15,12)] were not well
FIGURE 2 Model-predicted fractions of dose for
[13C10]- and [
13C5]retinol over time. Observed data
(symbols) and model-predicted fraction of dose
(lines) for [13C10]retinol (derived from the ingested
[13C10]retinyl acetate dose) and for [
13C5]retinol
(derived from the ingested [13C10]b-carotene dose)
compared with time in 1 representative healthy
young-adult subject. Also indicated are times at
which individual kinetic parameters are most sen-
sitive to the data. The model is shown in Figure 1.
DT(3), delay time in component 3.
TABLE 1 Baseline characteristics, dietary intake, and fasting
plasma concentrations in healthy young adults of
European ancestry1
Values
Subject characteristics
Age, y 24.5 6 4.0
Weight, kg 65.2 6 10.0
BMI, kg/m2 22.5 6 1.9
Fat, % 20.9 6 8.1
Dietary intake
Energy, kcal/d 2480 6 698
Carbohydrate, g/d 307 6 99.6
Fat, g/d 89.3 6 32.5
Protein, g/d 94.9 6 32.7
b-Carotene, μg/d 4610 6 4460
Retinol, μg/d 461 6 501
Plasma
b-Carotene, μmol/L 0.55 6 0.33
Retinol, μmol/L 1.53 6 0.27
TGs, mmol/L 0.91 6 0.37
Cholesterol, mmol/L 4.91 6 0.91
1 Values are means 6 SDs, n = 13 men and n = 17 women.
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identified as evidenced by large FSDs (data not shown); all others
were well identified (mean FSD = 0.10 6 0.042). The processes
of chylomicron production andmetabolism as well as the uptake
of chylomicron remnants by hepatocytes took an average of
2.7 h (delay time in component 3 [DT(3)]3 24 h/d); 5.5 pools of
plasma retinol were transferred to the extravascular compartment
(compartment 6) each day; 17% of vitamin A in compartment 6
recycled to plasma each day, and 6.0% was irreversibly lost each
day. By using the L(I,J)s for each individual along with their
calculated plasma retinol pool size [mean M(5) = 4.3 6 0.91
mmol], the following parameters were calculated by using a steady
state solution in WinSAAM: M(6) = 123 6 71 mmol, disposal
rate (DR) = 6.7 6 3.1 mmol/d, FCR(6,5) = 0.060 6 0.023 d21,
FCR(5,5) = 1.66 0.76 d21,mean time to plasma (TTP50%) = 176
3.0 h, t1/2(5) = 3.5 6 1.4 h, t1/2(6) = 3.7 6 1.6 d, T(5,5) = 0.79 6
0.37 d, T(6,5) = 196 7.4 d, T(SYS) = 206 7.5 d, v(5) = 4.66 2.1,
and tt(5) = 4.8 6 2.3 d.
Kinetic data and compartmental model for [13C5]retinol.
The lower curve in Figure 2 shows observed and simulated data
for the FD in plasma [13C5]retinol (derived from the [
13C10]b-
carotene dose) vs. time in the same subject as plotted in the upper
curve. Note that the 2 curves appear parallel from ;12 h after
dosing; this was true for all subjects in the current analysis.
By using the results from the [13C10]retinol data, we
developed a parallel model for plasma [13C5]retinol (Figure
1B). The initial aspects of the 2 models (absorption and
chylomicron metabolism) were independent, but the values for
the parameters related to plasma retinol were the same in the
[13C5]- and [
13C10]retinol models; specifically, L(16,15) = L(6,5),
L(15,16) = L(5,6), and L(20,16) = L(10,6). In the parallel model,
compartment 11 represents b-carotene transit and absorption
into enterocytes, and compartment 12 comprises the portion of
absorbed b-carotene converted to retinol. Because a wide range
of absorption and bioconversion efficiencies have been reported
for b-carotene (15), we allowed irreversible loss of the unab-
sorbed dose [L(0,11)] to vary among individuals [L(0,11) =
P(11)3 L(12,11), where P(11) is a proportionality constant used
to estimate the fraction of b-carotene not converted to retinol as
determined from the [13C5]retinol data for each subject].
The vast majority of the b-carotene converted to retinol in
enterocytes enters delay component 13, which represents the
processes of chylomicron formation and metabolism and the
uptake of chylomicron remnants by hepatocytes. The delay time
in component 13 was 0.152 d 3 24 h/d = 3.6 h (Table 2). As in
the [13C10]retinol model, compartment 14 represents hepatocyte
processing of chylomicron remnant retinol and hepatic secretion
of retinol bound to RBP, compartment 15 comprises plasma
retinol bound to RBP, and compartment 16 represents the vitamin
A in extravascular stores that exchanges with retinol in compart-
ment 15 and is the site of irreversible loss.
b-Carotene bioefficacy. Mean b-carotene bioefficacy calcu-
lated by using WinSAAM was 13.5% 6 6.02% (range: 4–32%)
or 7.7:1.0 mg RAEs. There was extensive interindividual var-
iation in b-carotene bioefficacy (CV: 44%). The subject whose
data are plotted in Figure 2 had a bioefficacy of 14%; over
all subjects, the closer the curves, the higher the bioefficacy
(Figure 3). Values calculated by WinSAAM were not signif-
icantly different from those determined by using KaleidaGraph
(13.1% 6 5.75%; range: 4.5–31%; P = 0.23). Least-squares
linear regression analysis (Figure 4) indicates that estimates
generated by the 2 methods were significantly correlated (r =
0.95, Rs = 0.93; P < 0.001).
Discussion
In this report, we add to the existing knowledge on whole-body
vitamin A metabolism in humans through the application of
model-based compartmental analysis to the data of Oxley et al.
(10), and we use modeling as an independent approach to
compare with graphical methods for estimating b-carotene
bioefficacy. To our knowledge, our analyses provide new
information on retinol kinetics in a relatively large sample (n =
30) of healthy young adults (mean age: 24 6 4 y) of European
ancestry. We found that the structure of the 6-component model
developed by Cifelli et al. (4) for older Chinese and American
adults [54 6 4 y (n = 14) and 59 6 9 y (n = 12), respectively]
provided a good fit to the current data, with a minor modifi-
cation needed in the site of loss of the unabsorbed oral doses and
with adjustment of the parameter values. Modeling revealed that
total body stores of vitamin Awere lower (1236 71 mmol) in the
current Newcastle volunteers than in the Chinese (233 6 109
mmol) or American (892 6 637 mmol) subjects. Although the
Newcastle subjects were selected for their low to moderate
vitamin A intakes, our analysis further underscores their
relatively low vitamin A status, in that they had only 18 d of
vitamin A stores (compared with 42 d in the Chinese and 61 d in
the Americans), where ‘‘days of stores’’ was calculated as model-
predicted micromoles of total body stores/disposal rate (mmol/d).
Note that, as was the case in the Chinese and American subjects,
plasma retinol concentrations were normal in the Newcastle
volunteers (1.54 6 0.28 mmol/L). That is, there was a high
prevalence of low total body stores of vitamin A in the
Newcastle cohort despite normal plasma retinol concentrations.
Similar findings of low vitamin A stores and normal plasma retinol
concentrations have been reported in both adult Bangladeshi men
[60 mmol (16)] and in Thai children [108 mmol (17)]. Our results
show that this combination can also be found in a European
group of young adults with low to moderate intakes of preformed
vitamin A. Interestingly, although the current study was much
shorter (14 d) than earlier investigations (4), which were carried
out for 53–56 d, when we modeled the first 14 d of data for the
TABLE 2 Model-predicted parameters for retinol kinetics in
healthy young adults of European ancestry1
Parameter Value
L(2,1) 24.2 6 39.0
L(5,2) 0.114 6 0.191
DT(3) 0.113 6 0.0442
L(5,4) 2.98 6 5.18
L(6,5) 5.50 6 2.11
L(5,6) 0.169 6 0.108
L(10,6) 0.0599 6 0.0231
L(15,12) 0.110 6 0.205
DT(13) 0.152 6 0.0327
L(15,14) 1.43 6 0.872
P(11) 10.9 6 5.54
1 Values are means 6 SDs, n = 30. Parameters are fractional transfer coefficients
[L(I,J)] or the fraction of retinol in compartment J that is transferred to compartment I
each day. For example, L(6,5) is the fractional transfer of retinol to compartment 6
(stores) from compartment 5 (plasma) (d21) and L(5,6) is the fractional transfer of
retinol back to plasma from stores (d21). L(0,11), the fraction of the oral dose of
b-carotene that was not absorbed, was calculated as P(11) 3 L(12,11), where P(11) is
a constant. L(0,1) = 0.3333 L(2,1), L(16,15) = L(6, 5), L(15,16) = L(5,6), L(20,16) = L(10,6),
and L(2,1) = L(3,2) = L(12,11) = L(13,12). The model is shown in Figure 1. DT(3) and
DT(13), delay times in components 3 and 13, respectively.
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American subjects in that previous study, the average model-
predicted total body vitamin A stores were only ;9% lower than
those determined on the basis of data for the full experimental
period, and values were identical for several individuals. This
indicates that a shorter study, perhaps ;28 d, may be adequate
for estimating total body vitamin A stores on the basis of a
compartmental model.
Comparing other model parameters between the 2 studies,
retinol recycling time was much lower in the Newcastle subjects
[tt(5) = 4.8 d] than that determined for individuals studied by
Cifelli et al. (4) [tt(5) = 18–20 d], due to the former groups lower
vitamin A stores. In contrast, the number of times an average
retinol molecule recycled from tissues to plasma before it was
irreversibly utilized (recycling number) was similar in the 3
groups [v(5) = 4] but lower than that calculated for rats [v(I) = 8–11]
(18, 19). The model-predicted disposal rate in the Newcastle
subjects (6.7 6 3.1 mmol/d) fell between that calculated for the
Chinese (5.6 6 2.0 mmol/d) and American (14.7 6 5.9 mmol/d)
subjects, and the system FCR was higher in the Newcastle group
(6.0% 6 2.3%/d compared with 2.6% 6 0.8% and 2.0% 6
0.7%/d). These differences are likely attributable to the differ-
ences in stores and the duration of the current study.
It is worth mentioning that, in the current subjects, the
kinetics of [13C10]retinol (from the [
13C10]retinyl acetate dose)
and [13C5]retinol (from the [
13C10]b-carotene dose) were the
same once retinol entered plasma bound to RBP. That is, based
on visual inspection, the plasma response curves were parallel
from ;12 h after dosing (Figure 2). The fact that the curves are
parallel indicates both that retinol from the 2 sources was
handled equivalently after secretion from the liver on RBP and
that there were no isotope effects due to the different number of
[13C] atoms (10 compared with 5) in retinol from the 2 stable
isotope doses.
The relative disposition of the plasma isotope response curves
also led us to hypothesize that there might be a more direct way
to estimate b-carotene bioefficacy than from the ratio of the
AUCs. Specifically, the ratio of the 2 stable isotopes in a given
plasma sample may provide a reliable index of bioefficacy, as
FIGURE 3 Fractions of dose in plasma
[13C10]retinol (derived from ingested [
13C10]
retinyl acetate) and [13C5]retinol (derived from
the ingested dose of [13C10]b-carotene) vs.
time for the subject with the highest (A) and
lowest (B) b-carotene bioconversion effi-
ciency. Symbols correspond to observed data
and lines correspond to model simulations;
the model is shown in Figure 1.
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suggested earlier by Hickenbottom et al. (20). In the current
subjects, the mean plasma retinol isotope ratio on day 2 was
12.5% 6 5.74% (compared with 13.5% on the basis of
WinSAAM). Further work will be needed to explore the validity
of a plasma isotope ratio method for estimating b-carotene
bioefficacy; however, if it is confirmed, it would allow the
estimation of this factor on the basis of analysis of a single blood
sample rather than requiring a relatively long-term study with
multiple blood samples (which is needed to estimate AUC).
Although b-carotene bioefficacy varied widely among indi-
viduals in this study (CV: 44%), we found that estimates
generated by graphical analysis as described by Tang et al. (6)
were confirmed by WinSAAM. Mean bioefficacy from a
physiologic dose of b-carotene (2 mg) in oil was 13.5% in the
current subjects. This estimate is similar to values reported by
Tang (21) for subjects who were given 1.5 mg [2H8]b-carotene in
oil (14%; RAEs: 7.4:1.0 mg) and those determined for the
American and Chinese subjects studied by Tang and colleagues
(6, 7) (11% bioefficacy; RAEs: 9.1:1.0 mg) after doses of 6 mg
deuterated b-carotene in oil. However, relative b-carotene
bioefficacy calculated for the current subjects is lower than
that predicted by the FAO/WHO (30%; RAEs: 3.3:1.0 mg) and
by the USNational Academy ofMedicine (50%; RAEs: 2.0:1.0mg)
for b-carotene in oil (22, 23). Because b-carotene bioefficacy is
affected by many experimental factors, including size of dose,
dosing regimen, and food matrix (9), as well as by interin-
dividual subject factors such as vitamin A status and genetic
variations in the b-carotene 15,15’-dioxygenase 1 cleavage en-
zyme (6, 24, 25), much more work is needed to understand dif-
ferences in absorption and metabolism of b-carotene and other
carotenoids.
In conclusion, the application of model-based compartmen-
tal analysis has the potential to provide unique information and
insights into vitamin A and b-carotene kinetics and metabolism
as well as practical results with the potential for application in
the field. For example, in the accompanying article in this issue
(26), we used modeling results to modify the original retinol
isotope dilution equation (27) for predicting total body vitamin
A stores on the basis of a single, early blood sample. Similarly,
our current modeling results confirm graphical methods for
estimating b-carotene bioefficacy and may lead to a simpler
method that will be useful in the field.
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